CannabisNewsBreaks

TuesdayNov 14, 2017 11:43 am

CannabisNewsBreaks – ChineseInvestors.com, Inc.’s (CIIX) ChineseHempOil.com Subsidiary Launches OptHemp Product Line on Amazon (NASDAQ: AMZN) During Singles Day Celebration

ChineseHempOil.com, a wholly owned subsidiary of ChineseInvestors.com (OTCQB: CIIX), this morning said that it recently launched its OptHemp product line on Amazon.com (NASDAQ: AMZN) initiating a multi-channel campaign targeting both the US and Chinese-American markets. The launch is aligned during the 9th annual Singles Day Celebration and marks the company’s first use of Amazon for product sales. The launch also marks the beginning of the e-commerce marketplace initiative the company began in June through its strategic partnership with Quiverr Collective, a wholly owned subsidiary of Advantage Solutions. Per the agreement, Quiverr has agreed to include the OptHemp product line in…

Continue Reading

MondayNov 13, 2017 3:16 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Covered in November ‘Let’s Toke Business’ Report Alongside Canopy Growth (TSX: WEED)

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has been featured in the November issue of ‘Let’s Toke Business.’ The report draws similarities between Lexaria and Canopy Growth (TSX: WEED), as both companies have had major breakouts on the stock market recently. The ability of Lexaria’s technology to expand into other markets was mentioned in the report, as well the possibility that non-cannabis applications could demonstrate an even greater potential. On November 9, Lexaria announced that it filed a new patent application with the U.S. Patent and Trademark…

Continue Reading

MondayNov 13, 2017 12:25 pm

CannabisNewsBreaks – ChineseInvestors.com, Inc.’s (CIIX) Investor Relations Division Generates Substantial Revenues

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) reported a 76% year-over-year jump in operating sales in fiscal 2017. The company’s Investor Relations division boasted as the largest generator of corporate three-month revenues, contributing 62% of CIIX’s total sales for the period. An article discussing this reads: “ChineseInvestors.com, Inc. (OTCQB: CIIX) is driving revenue growth from its Investor Relations Division, realizing a 186% jump in sales for 1QFY2018. The first quarter revenue in FY2018 in this segment was $258,366 compared to sales of $90,312 in the first quarter of FY2017. To generate growth in FY2018, CIIX developed new products, such as…

Continue Reading

MondayNov 13, 2017 9:53 am

CannabisNewsBreaks – Global Payout, Inc.’s (GOHE) MoneyTrac Subsidiary to Attend MJ Business Conference in Las Vegas

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”), will be attending the MJ Business Conference and Expo November 14-17 in Las Vegas, Nevada. MTRAC recently acquired PotSaver, a marketing and publishing entity founded by Aaron Adler. Adler will join MTRAC CEO James Hancock and COO Vanessa Luna at the expo to promote the MTRAC and PotSaver brands while networking with other cannabis industry executives at the event. “Attending this event will be an excellent opportunity for us to share the vast array of technology and business-related solutions MoneyTrac…

Continue Reading

FridayNov 10, 2017 3:00 pm

CannabisNewsBreaks – EVIO, Inc. (EVIO) Engages Macdonald Tuskey for Potential Entry into Canadian Capital Markets

Leading provider of cannabis analytical testing services EVIO, Inc. (OTCQB: EVIO) recently engaged the Macdonald Tuskey law firm regarding its entry into the Canadian capital markets. The law firm has been engaged to assist the company in navigating the potential listing opportunities, related requirements and compliance in Canada. EVIO’s objective of listing its stock on the Canadian capital market could result in increased liquidity and an improved ability to raise capital for the company. A new listing may also increase EVIO’s visibility in the booming Canadian cannabis market. For more information, visit: www.EvioLabs.com About EVIO, Inc. EVIO, Inc. is an…

Continue Reading

FridayNov 10, 2017 9:53 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Regains Listing Compliance

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has regained NYSE American listing compliance. The company received a letter on November 9, 2017, from NYSE Regulation stating that it is currently in compliance with the NYSE American LLC continued listing standards set forth in section 704 of the NYSE American Company Guide. This update came on the heels of IGC’s annual meeting, which took place on November 8, 2017. As noted in this morning’s news release, the company’s listing eligibility will continue to be…

Continue Reading

ThursdayNov 09, 2017 2:20 pm

CannabisNewsBreaks – AppSwarm, Inc. (SWRM) Applies Technical Expertise to Enter Cannabis Mobile App Market with Partner SinglePoint, Inc. (SING)

Developer and publisher of mobile gaming apps AppSwarm, Inc. (OTC: SWRM) is utilizing its technical expertise to enter the cannabis mobile app market in partnership with SinglePoint, Inc. (OTC: SING). An article discussing this reads: “As the two companies join forces, described in the LOI, it provides SWRM a significant platform for providing its technical and app development knowledge. They will first develop a service-based app for the business-to-business and business-to-consumer markets and provide a base for the development of future apps. The products will represent SWRM’s entry into the cannabis market and will be branded and marketed under SinglePoint’s…

Continue Reading

ThursdayNov 09, 2017 11:56 am

CannabisNewsBreaks – Grey Cloak Tech, Inc.’s (GRCK) Subsidiary Eqova Products to be Presented at MJBizCon

In an all-stock transaction last month, Grey Cloak Tech, Inc. (OTCQB: GRCK) acquired 100% of Eqova Life Sciences. The company is attending a conference in Las Vegas where Eqova’s products will be seen by potentially thousands of cannabis-related executives. An article discussing this reads: “Grey Cloak Tech, Inc. (OTCQB: GRCK), through subsidiary Eqova Life Sciences, will introduce CannaBio Salve at the Marijuana Business Conference (MJBizCon), to be held November 14-17 in Las Vegas (http://cnw.fm/LB0Jm). Per the announcement, it is the industry’s premier cannabis trade show. CannaBio Salve is a topical skin product containing full spectrum hemp oil, menthol and essential…

Continue Reading

ThursdayNov 09, 2017 11:16 am

CannabisNewsBreaks – Marijuana Company of America (MCOA) Completes Financing for Bougainville Ventures JV Agreement

Marijuana Company of America Inc. (OTC: MCOA), an innovative hemp and cannabis corporation, this morning announced that it has completed its financing of $800,000 in cash and 15 million shares of the company’s common stock in full satisfaction of the amended terms of its joint venture agreement with Bougainville Ventures, Inc. ("BV"). Per the terms of the agreement and with the completion of funding, MCOA has secured a 50 percent equity stake in BV-MCOA Management, LLC and will receive 50 percent of the net profits from leasing the planned facility, which will accommodate a contracted cannabis production and processing tenant…

Continue Reading

ThursdayNov 09, 2017 10:43 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Announces Filing of New Patent Application with USPTO

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, this morning announced that it has filed a new patent application with the U.S. Patent and Trademark Office (“USPTO”) covering the use of its DehydraTECH™ technology for the delivery of phosphodiesterase type 5 (PDE5) inhibitors. Existing products occupying this space include Viagra™ (sildenafil) and Cialis™ (tadalafil). Per the update, a common complaint regarding existing PDE5 inhibitors relates to the slow-acting nature of the substances. Lexaria believes that its patented DehydraTECH™ technology, building on existing research with cannabinoid delivery, will…

Continue Reading